MEP of the week

Lobby organisation

Gilead Sciences

Company · Health & pharma · HQ: United States · Transparency Register entry

As of 7 November 2026, Gilead Sciences appears in 29 declared MEP meetings (15 different MEPs), most often with Socialists & Democrats.

29
declared meetings
with current MEPs
15
MEPs met
€1.0M/yr
declared lobbying spend
self-reported to the register
2.2
lobbyists
full time equivalent

In their own words

“Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 38 countries worldwide.”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 29 declared meetings, by the meeting MEP's political group.

Socialists & Democrats1345%
European People's Party1034%
Renew Europe517%
European Conservatives & Reformists13%

Meetings by year

Declared meetings per calendar year, 2022–2026. Bar length is relative to its busiest year (10 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.

2022
1
2023
7
2024
9
2025
2
2026
10

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Dolors Montserrat
5 meetings · EPP
András Tivadar Kulja
2 meetings · EPP
Michalis Hadjipantela
2 meetings · EPP
Tiemo Wölken
1 meeting · S&D

The 15 most recent declared meetings

DateMEPSubject
26 Oct 2026Kristian VigeninHIV advocacy
21 Oct 2026Morten LøkkegaardBiotech
20 Oct 2026Tiemo WölkenHIV
20 Oct 2026Michalis HadjipantelaBiotech Act updates
20 Oct 2026Nicolás González CasaresATMPs development & HIV Policy
1 Jul 2026Marc AngelEvent on HIV prevention
8 May 2026Stine BosseBiotech Act
21 Apr 2026András Tivadar KuljaHIV treatment and prevention in Europe
16 Mar 2026Dan BarnaEuropean policies regarding health and life sciences
10 Feb 2026Nicolás González CasaresBiotech
8 Jul 2025Dolors MontserratReview of the EU General Pharmaceutical Legislation
26 May 2025Dolors MontserratCancer treatments and HIV vaccines
4 Nov 2024Michalis HadjipantelaIntroductory meeting
24 Oct 2024Olivier ChastelPolitique de santé de l Union européenne
23 Oct 2024András Tivadar KuljaHIV vaccination

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.